Corinne Le Goff

Corinne Le Goff is the Chief Commercial Officer of Viatris. She joined the company in April 2024.

Corinne is an accomplished biotechnology and pharmaceutical executive with more than 25 years of experience leading and building highly successful teams globally. She is a visionary and entrepreneurial leader with a strong scientific background and experience across multiple markets and therapeutic areas.

Prior to joining Viatris, Corinne was President and Chief Executive Officer of Imunon, a clinical-stage biotechnology company, where she led an organizational turnaround and rebranding effort. Prior Imunon, she served as Chief Commercial Officer at Moderna, with responsibility for building the commercial organization and key capabilities to ensure global access to the company’s COVID-19 vaccine. Corinne previously spent six years at Amgen, serving as President of the U.S. Business; Senior Vice President of Global Product Strategy & Commercial Innovation; and President of the Europe Region. She also held senior international roles at Roche, including President of Roche France and Head of Global Product Strategy, Neuroscience & Rare Diseases. Early in her career, she held various leadership positions at Merck, Sanofi and Pfizer.

Corinne earned a Pharm. D. from Paris Descartes University and a Master of Business Administration from La Sorbonne University, both in Paris.

She is a member of the Longboard Pharmaceuticals board of directors and has served previously on the boards of Euroapi, Acticor Biotech, CFAO Group and Amgen Foundation.